Prostate Cancer Severity Predicted With Two Genetic Signatures
10/09/2012
Two separate genetic signatures seem to be able to tell how severe a patient's prostate cancer is going to be, which would dramatically improve prognoses and make it easier for doctors to decide on the most appropriate treatment early on, American and British researchers report in two articles published today in the journal The Lancet Oncology...
New Research Takes Us Another Step Towards Understanding And Treating Melanoma
10/09/2012
These proteins are required for melanocyte stem cell self-maintenance and, as such, correct pigmentation throughout the mice's life span. Without these two proteins, the mice's fur turns white. Their research is published in the review Cell Report and paves the way for serious possibilities in terms of stopping the formation of melanomas, tumours that originate from melanocyte cells...
Drinking Milk Said To Protect From Colon Cancer Progression
10/09/2012
A protein that exists in milk can significantly reduce the rate at which colon cancer cells grow over time, researchers from the University of Lund, Sweden, reported in the Journal of Dairy Science, the official journal of the American Dairy Science Association. Previous studies have shown that milk can reduce the risk of developing diabetes and metabolic syndrome...
Learning About Nausea Through 'Disgusted' Rats: Research May Lead To New Cancer Treatments
10/09/2012
Nausea is a common and distressing side effect of many drugs and treatments. Unlike vomiting, nausea is not well understood, but new research by University of Guelph scientists may soon change that. Guelph PhD student Katharine Tuerke, neuroscience researcher Cheryl Limebeer and Prof...
A Molecular Scissor Related To Alzheimer's Disease
10/09/2012
An international research team led by the Spanish National Research Council (CSIC) and researchers from Kiel University revealed the atomic-level structure of the human peptidase enzyme meprin β (beta). The study was published online in the journal Proceedings of the National Academy of Sciences...
Treating HER2+ Breast Cancer With HIV Drug
10/09/2012
The HIV protease inhibitor, Nelfinavir, can be used to treat HER2-positive breast cancer in the same capacity and dosage regimen that it is used to treat HIV, according to a study published in the Journal of the National Cancer Institute. Breast cancer is one of the most common causes of cancer deaths in the U.S. with approximately 39,520 women succumbing to the disease in 2011...
New Blood Tests To Put Clinical Trials For Allergic Asthma On The Fast Track
10/09/2012
The Centre of Excellence for the Prevention of Organ Failure (PROOF Centre) and AllerGen NCE (Allergy, Genes and Environment Network of Centres of Excellence) are working together to develop blood tests that will speed up clinical trials investigating the efficacy of drugs treating allergic disease...
Important Advance Towards Understanding The Mechanisms Of Colon Cancer Progression
10/08/2012
Researchers from IMIM, Hospital del Mar Medical Research Institute, have succeeded in determining the function of a new variant of enzyme IKKalpha (IKKα) to activate some of the genes taking part in the tumor progressions of colorectal cancer...
Chemical Found In Many Plastics Linked To Multiple Health Threats
10/08/2012
Bisphenol A or BPA is a synthetic chemical widely used in the making of plastic products ranging from bottles and food can linings to toys and water supply lines. When these plastics degrade, BPA is released into the environment and routinely ingested...
Scientists at USC have discovered a new type of drug for the treatment of ovarian cancer that works in a way that should not only decrease the number of doses that patients need to take, but also may make it effective for patients whose cancer has become drug-resistant...